99 related articles for article (PubMed ID: 24555238)
1. Post-operative management of primary glioblastoma multiforme in patients over 60 years of age.
Daróczi B; Szántó E; Tóth J; Barzó P; Bognár L; Bakó G; Szántó J; Mózes P; Hideghéty K
Ideggyogy Sz; 2013 Nov; 66(11-12):391-8. PubMed ID: 24555238
[TBL] [Abstract][Full Text] [Related]
2. Prolonged Temozolomide Maintenance Therapy in Newly Diagnosed Glioblastoma.
Skardelly M; Dangel E; Gohde J; Noell S; Behling F; Lepski G; Borchers C; Koch M; Schittenhelm J; Bisdas S; Naumann A; Paulsen F; Zips D; von Hehn U; Ritz R; Tatagiba MS; Tabatabai G
Oncologist; 2017 May; 22(5):570-575. PubMed ID: 28360216
[TBL] [Abstract][Full Text] [Related]
3. Treatment of very elderly glioblastoma patients ≥ 75 years of age: whom to treat.
Baumgarten P; Prange G; Kamp MA; Monden D; Neef V; Schwarzer F; Dubinski D; Dinc N; Weber KJ; Czabanka M; Hattingen E; Ronellenfitsch MW; Steinbach JP; Senft C
J Neurooncol; 2023 Dec; 165(3):509-515. PubMed ID: 38032426
[TBL] [Abstract][Full Text] [Related]
4. The role of adjuvant chemotherapy in patients with H3K27 altered diffuse midline gliomas: a multicentric retrospective study.
Di Nunno V; Lombardi G; Simonelli M; Minniti G; Mastronuzzi A; Di Ruscio V; Corrà M; Padovan M; Maccari M; Caccese M; Simonetti G; Berlendis A; Farinotti M; Pollo B; Antonelli M; Di Muzio A; Dipasquale A; Asioli S; De Biase D; Tosoni A; Silvani A; Franceschi E
J Neurooncol; 2024 Mar; 167(1):145-154. PubMed ID: 38457090
[TBL] [Abstract][Full Text] [Related]
5. Extended dosing (12 cycles) vs conventional dosing (6 cycles) of adjuvant temozolomide in adults with newly diagnosed high-grade gliomas: a randomized, single-blind, two-arm, parallel-group controlled trial.
Anvari K; Seilanian Toussi M; Saghafi M; Javadinia SA; Saghafi H; Welsh JS
Front Oncol; 2024; 14():1357789. PubMed ID: 38774410
[TBL] [Abstract][Full Text] [Related]
6. Controversies in the adjuvant therapy of high-grade gliomas.
Holdhoff M; Grossman SA
Oncologist; 2011; 16(3):351-8. PubMed ID: 21339260
[TBL] [Abstract][Full Text] [Related]
7. Glioblastoma in the oldest old: Clinical characteristics, therapy, and outcome in patients aged 80 years and older.
Stadler C; Gramatzki D; Le Rhun E; Hottinger AF; Hundsberger T; Roelcke U; Läubli H; Hofer S; Seystahl K; Wirsching HG; Weller M; Roth P
Neurooncol Pract; 2024 Apr; 11(2):132-141. PubMed ID: 38496908
[TBL] [Abstract][Full Text] [Related]
8. Butterfly gliomas: a time for stratified management?
Sinha S; Avnon A; Perera A; Lavrador JP; Ashkan K
Neurosurg Rev; 2023 Sep; 46(1):223. PubMed ID: 37665387
[TBL] [Abstract][Full Text] [Related]
9. Association between post-operative hPG
Doucet L; Cailleteau A; Vaugier L; Gourmelon C; Bureau M; Salaud C; Roualdes V; Samarut E; Aumont M; Zenatri M; Loussouarn D; Quillien V; Bocquet F; Payen-Gay L; Joubert D; Prieur A; Robert M; Frenel JS
ESMO Open; 2023 Oct; 8(5):101626. PubMed ID: 37713930
[TBL] [Abstract][Full Text] [Related]
10. Guiding Treatment Choices for Elderly Patients with Glioblastoma by a Comprehensive Geriatric Assessment.
Lütgendorf-Caucig C; Freyschlag C; Masel EK; Marosi C
Curr Oncol Rep; 2020 Jul; 22(9):93. PubMed ID: 32651730
[TBL] [Abstract][Full Text] [Related]
11. Unusual presentation of glioblastoma in the brainstem: a case report of a diffuse pontine glioblastoma multiforme and surgical management.
Edelbach B; Gospodarev V; Lopez-Gonzalez M; Deisch J; Kaur M
Front Oncol; 2024; 14():1279897. PubMed ID: 38544840
[TBL] [Abstract][Full Text] [Related]
12. Repeat resection for recurrent glioblastoma in the temozolomide era: a real-world multi-centre study.
Woo PYM; Law THP; Lee KKY; Chow JSW; Li LF; Lau SSN; Chan TKT; Ho JMK; Lee MWY; Chan DTM; Poon WS
Br J Neurosurg; 2023 Jan; ():1-9. PubMed ID: 36654527
[TBL] [Abstract][Full Text] [Related]
13. Peritumoral brain zone in glioblastoma: biological, clinical and mechanical features.
Ballestín A; Armocida D; Ribecco V; Seano G
Front Immunol; 2024; 15():1347877. PubMed ID: 38487525
[TBL] [Abstract][Full Text] [Related]
14. State of the neoadjuvant therapy for glioblastoma multiforme-Where do we stand?
Nabian N; Ghalehtaki R; Zeinalizadeh M; Balaña C; Jablonska PA
Neurooncol Adv; 2024; 6(1):vdae028. PubMed ID: 38560349
[TBL] [Abstract][Full Text] [Related]
15. Dosimetric patterns of failure in the era of novel chemoradiotherapy in newly-diagnosed glioblastoma patients.
Seaberg MH; Kazda T; Youland RS; Laack NN; Pafundi DH; Anderson SK; Sarkaria JN; Galanis E; Brown PD; Brinkmann DH
Radiother Oncol; 2023 Nov; 188():109768. PubMed ID: 37385378
[TBL] [Abstract][Full Text] [Related]
16. Recurrent Glioblastoma: From Molecular Landscape to New Treatment Perspectives.
Birzu C; French P; Caccese M; Cerretti G; Idbaih A; Zagonel V; Lombardi G
Cancers (Basel); 2020 Dec; 13(1):. PubMed ID: 33375286
[TBL] [Abstract][Full Text] [Related]
17. Anti-neoplastic Potential of Flavonoids and Polysaccharide Phytochemicals in Glioblastoma.
Atiq A; Parhar I
Molecules; 2020 Oct; 25(21):. PubMed ID: 33113890
[TBL] [Abstract][Full Text] [Related]
18. Impact of remoteness and rurality on the treatment and survival of patients with glioblastoma in the north of Scotland.
Veljanoski D; Barlas R; Jamjoom AAB; Walkden J; Horgan G; Moleron R; Myint PK; Giamouriadis A
World Neurosurg X; 2024 Apr; 22():100331. PubMed ID: 38455242
[TBL] [Abstract][Full Text] [Related]
19. Paediatric cerebellar glioblastoma - long-term survival following surgery and adjuvant chemoradiotherapy: A case report and literature review.
Sanders MI; Gatt D; Lee V; Wharton SB; Bagga V
Brain Spine; 2024; 4():102819. PubMed ID: 38706801
[TBL] [Abstract][Full Text] [Related]
20. Giant cell glioblastoma in 6-year-old kid: Report of an unusual case.
Shrestha S; Homagain S; Raut A; Sedhain G; Bhatta S; Shrivastav S
Clin Case Rep; 2020 Dec; 8(12):2936-2940. PubMed ID: 33363854
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
